Evidence map›Paper›PMID 15875173›Full record

ReviewUrological research2005

Preventive treatment of nephrolithiasis with alkali citrate--a critical review.

D Mattle, B Hess

Registry-linked trialOpen access · bronzeAbstract readReview
PubMed Publisher
In one paragraph

Review in Urological research, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04073719 (Apple Cider Vinegar for the Prevention of Urinary Lithiasis), which is not on this map. Cited by 38 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 2 pooled it
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04073719 naunknown statusnot on this mapstarted 2019, after this paper: background citation

Apple Cider Vinegar for the Prevention of Urinary Lithiasis (APUL)

TypeinterventionalSponsorUnited States Naval Medical Center, San DiegoRan2019 to 2022Enrolled50ConditionsKidney Stones, Urolithiasis, HypocitraturiaArmsApple Cider Vinegar, Other Beverage
3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 2 syntheses or guidelines pooled it, 105 citations in OpenAlex.

  1. Pooled it
  2. Guideline
  3. Trial
  4. Trial
  5. Medical treatment of uric acid kidney stones.Canadian Urological Association journal = Journal de l'Association des urologues du Canada · 2024
    Article
  6. Article
  7. Lime juice as a dietary alternative to mist potassium citrate for urine alkalinisation: A prospective, cross-over clinical trial.Malaysian family physician : the official journal of the Academy of Family Physicians of Malaysia · 2023
    Article
  8. UPDATE - Canadian Urological Association guideline: Evaluation and medical management of kidney stones.Canadian Urological Association journal = Journal de l'Association des urologues du Canada · 2022
    Article
  9. Article
  10. Article
  11. Article
  12. Coconut Water: An Unexpected Source of Urinary Citrate.BioMed research international · 2018
    Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

D MattleDepartment of Internal Medicine, Regional Hospital, 3600 Thun, Switzerland.
B Hess
Western Regional Hospital · NPZimmer (Switzerland) · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Using the keywords "urolithiasis and citrate treatment", "nephrolithaisis and citrate treatment", "kidney stones and citrate treatment", a Medline search revealed 635 articles published between 1 January 1966 and 1 December 2004. For the present analysis, only studies meeting all of the following criteria were included: (1) publications in English or German, (2) studies on preventive alkali citrate treatment in patients with calcium oxalate, uric acid and infection stone disease, (3) clinical studies including at least ten subjects, and (4) treatment phases of at least 1 week duration. A total of 43 studies met the inclusion criteria and were further subclassified according to intermediate or ultimate endpoints as well as to study design. With stone recurrence as the ultimate endpoint, 21 uncontrolled studies in almost 1,000 patients demonstrated a reduction in stone forming rate by 47-100%. In four randomized controlled trials including 227 patients, 53.5% on alkali citrate vs 35% on placebo remained stone-free after at least 1 year of treatment (P<0.0005). Similar values (66% vs 27.5% for alkali citrate vs placebo, P<0.0005) were obtained in 104 patients from two randomized trials with dissolution/clearance of residual stones as endpoint. Unfortunately, up to 48% of alkali citrate treated patients left the studies prematurely, primarily due to adverse effects such as eructation, bloating, gaseousness or frank diarrhea.

Indexed as

AlkaliesCitric AcidHumansUrinary CalculiAlkaliesCitric Acid

Identifiers

PMID15875173
OpenAlexW1985253191

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.